Prevention of dementia using mobile phone applications (PRODEMOS): a multinational, randomised, controlled effectiveness-implementation trial.
Moll van Charante EP, Hoevenaar-Blom MP, Song M, Andrieu S, Barnes L, Birck C, Brooks R, Coley N, Eggink E, Georges J, Hafdi M, van Gool WA, Handels R, Hou H, Lyu J, Niu Y, Song L, Wang W, Wang Y, Wimo A, Yu Y, Zhang J, Zhang W, Brayne C, Wang W, Richard E; PRODEMOS study group.
Moll van Charante EP, et al.
Lancet Healthy Longev. 2024 Jun;5(6):e431-e442. doi: 10.1016/S2666-7568(24)00068-0. Epub 2024 May 16.
Lancet Healthy Longev. 2024.
PMID: 38763155
Free article.
Clinical Trial.
The primary effectiveness outcome was change in cardiovascular risk factors, ageing, and incidence of dementia (CAIDE) risk score from baseline to after 12-18 months of intervention. ...All participants with complete data on the primary outcome, without imputation o …
The primary effectiveness outcome was change in cardiovascular risk factors, ageing, and incidence of dementia (CAIDE) risk score fro …